FGF-1	NN
reverts	VBZ
epithelial-mesenchymal	JJ
transition	NN
induced	VBN
by	IN
TGF	NN
-	:
-LCB-	(
beta	NN
-RCB-	)
1	CD
through	IN
MAPK/ERK	NN
kinase	NN
pathway	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
progressive	JJ
and	CC
lethal	JJ
lung	NN
disease	NN
characterized	VBN
by	IN
the	DT
expansion	NN
of	IN
the	DT
fibroblast/myofibroblast	JJ
population	NN
and	CC
aberrant	JJ
remodeling	NN
.	.

However	RB
,	,
the	DT
origin	NN
of	IN
mesenchymal	JJ
cells	NNS
in	IN
this	DT
disorder	NN
is	VBZ
still	RB
under	IN
debate	NN
.	.

Recent	JJ
evidence	NN
indicates	VBZ
that	IN
epithelial-mesenchymal	JJ
transition	NN
(	(
EMT	NN
)	)
induced	VBD
primarily	RB
by	IN
TGF-beta1	NN
plays	VBZ
an	DT
important	JJ
role	NN
;	:
however	RB
,	,
studies	NNS
regarding	VBG
the	DT
opposite	JJ
process	NN
,	,
mesenchymal-epithelial	JJ
transition	NN
,	,
are	VBP
scanty	JJ
.	.

We	PRP
have	VBP
previously	RB
shown	VBN
that	IN
fibroblast	NN
growth	NN
factor-1	NN
(	(
FGF-1	NN
)	)
inhibits	VBZ
several	JJ
profibrogenic	JJ
effects	NNS
of	IN
TGF-beta1	NN
.	.

In	IN
this	DT
study	NN
,	,
we	PRP
examined	VBD
the	DT
effects	NNS
of	IN
FGF-1	NN
on	IN
TGF-beta1-induced	JJ
EMT	NN
.	.

A549	NN
and	CC
RLE-6TN	NN
(	(
human	JJ
and	CC
rat	NN
)	)
alveolar	JJ
epithelial-like	JJ
cell	NN
lines	NNS
were	VBD
stimulated	VBN
with	IN
TGF-beta1	NN
for	IN
72	CD
h	NN
,	,
and	CC
then	RB
,	,
in	IN
the	DT
presence	NN
of	IN
TGF-beta1	NN
,	,
were	VBD
cultured	VBN
with	IN
FGF-1	NN
plus	CC
heparin	NN
for	IN
an	DT
additional	JJ
48	CD
h	NN
.	.

After	IN
TGF-beta1	NN
treatment	NN
,	,
epithelial	JJ
cells	NNS
acquired	VBD
a	DT
spindle-like	JJ
mesenchymal	JJ
phenotype	NN
with	IN
a	DT
substantial	JJ
reduction	NN
of	IN
E-cadherin	NN
and	CC
cytokeratins	NNS
and	CC
concurrent	JJ
induction	NN
of	IN
alpha-smooth-muscle-actin	NN
measured	VBN
by	IN
real-time	JJ
PCR	NN
,	,
Western	NN
blotting	NN
,	,
and	CC
immunocytochemistry	NN
.	.

FGF-1	NN
plus	CC
heparin	NN
reversed	VBD
these	DT
morphological	JJ
changes	NNS
and	CC
returned	VBD
the	DT
epithelial	JJ
and	CC
mesenchymal	JJ
markers	NNS
to	TO
control	VB
levels	NNS
.	.

Signaling	NN
pathways	NNS
analyzed	VBN
by	IN
selective	JJ
pharmacological	JJ
inhibitors	NNS
showed	VBD
that	IN
TGF-beta1	NN
induces	VBZ
EMT	NN
through	IN
Smad	NN
pathway	NN
,	,
while	IN
reversion	NN
by	IN
FGF-1	NN
occurs	VBZ
through	IN
MAPK/ERK	NN
kinase	NN
pathway	NN
,	,
resulting	VBG
in	IN
ERK-1	NN
phosphorylation	NN
and	CC
Smad2	NN
dephosphorylation	NN
.	.

These	DT
findings	NNS
indicate	VBP
that	IN
TGF-beta1-induced	JJ
EMT	NN
is	VBZ
reversed	VBN
by	IN
FGF-1	NN
and	CC
suggest	VBP
therapeutic	JJ
approaches	NNS
to	TO
target	VB
this	DT
process	NN
in	IN
IPF	NN
.	.

